期刊文献+

HCV core 1b亚型和HA共表达重组腺病毒载体的构建与鉴定

Construction and Identification of Recombinant Adenovirus Vector Co-expressing HCV Core 1b and HA
原文传递
导出
摘要 目的:构建HCV core 1b亚型和HA共表达的腺病毒载体并予以鉴定。方法:合成HCV核心蛋白1b亚型的核苷酸,连接入pcmv5-HA质粒中。用XhoⅠ单酶切,后用Klenow酶补平,再用HindⅢ单酶切下HA-HCV core 1b片段,连入pShuttle-cmv穿梭质粒中,构建穿梭质粒pShuttle-CMV-HA core 1b.将pShuttle-CMV-HA core 1b转化至含有AdEasy-1的BJ5183感受态细菌中进行同源重组。PacⅠ酶切线性化重组质粒pAd-HA-HCV core 1b并转染AD293细胞进行病毒包装和扩增。用RT-PCR检测HA-HCVcore 1b的mRNA的表达水平,并用Western blot检测融合表达蛋白HA-HCV core 1b的表达水平。结果:穿梭质粒pShuttle-CMV-HA-HCV core 1b经PCR和测序证实构建成功。重组腺病毒载体经AD293细胞包装后,可观察到CPE现象。用获得的重组腺病毒载体感染AD293细胞,经RT-PCR检测,在mRNA水平上有表达;经Western blot检测,HCV core 1b亚型腺病毒载体(Ad-HA-HCV core 1b)感染组与未感染腺病毒载体组及空白对照组相比,只有Ad-HA-HCV core 1b感染组有融合蛋白HA-HCVcore 1b的表达。结论:通过分子克隆体外重组技术,成功构建了HCV core 1b亚型和HA共表达的重组腺病毒载体Ad-HA-HCVcore 1b。为进一步研究丙型肝炎病毒1b亚型引起丙肝感染中胰岛素抵抗的作用机制提供了方法。 Objective: To construct and identify the recombinant adenovirus vector of co-expression HCV core 1b and HA.Methods: The HCV gene was cloned and intested into a pcmv5-HA plasmid,then was connect into pShuttle-CMV plasmid and trans-formed the plasmid into E.coli DH5α.The recombinant plasmid pShuttle-CMV-HA-HCV core 1b was screened and transformed into BJ5183 to perform homologous recombination with pAdEasy-1.A recombinant adenovirus vector was acquired.Then it was transfected into AD293 cells to prepare the replication deficient adenovirus Ad-HA-HCV core 1b.AD293 cells was infected with Ad-HA-HCV core 1b and the expression of HA-HCV core 1b was detected by RT-PCR and western blot.Results:(1) The recombinant plasmid pShut-tle-CMV-HA-HCV core 1b were constructed successfully.(2)After recombination of pShuttle-CMV-HA-HCV core 1b and pAdEasy-1,the product was digested by restriction endonuclease PacI.In gel electrophoresis,they performed as the 3.0 kb segment which was as the same segment as prospection.(3) Ad-HA-HCV core 1b could infect AD293 cells and the extrinsic genes can be expressed in cells.Conclusion: The recombinant adenoviral vector Ad-HA-HCV core 1b was constructed successfully.
出处 《现代生物医学进展》 CAS 2011年第1期8-11,共4页 Progress in Modern Biomedicine
基金 国家自然科学基金81000171/H0316
关键词 HCV CORE 1b亚型 重组腺病毒载体 分子克隆 HA-HCV core 1b vector construction Recombinant adenovirus Molecular cloning
  • 相关文献

参考文献10

  • 1Chao-Pin Li Ke-Xia Wang Jian Wang,Department of Aetiology and Immunology,School of Medicine,Huainan University of Technology,Huainan 232001,Anhui Province,China Bo-Rong Pan,the Fourth Military Medical University.mIL-2R,T cell subsets & hepatitis C[J].World Journal of Gastroenterology,2002,8(2):298-300. 被引量:25
  • 2Moucari R, Asselah T, Cazals HD, et al. , Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis[J]. Gastroenterology, 2008. 134(2): 416-23.
  • 3Bukh J, Purcell RH, Miller RH. Sequence analysis of the core gene of 14 hepatitis C virus genotypes[J]. Proc Natl Acad Sci U S A, 1994, 91 (17): 8239-43.
  • 4Jager L, Ehrhardt A. Emerging adenoviral vectors for stable correction of genetic disorders[J]. Curr Gene Ther, 2007, 7(4): 272-83.
  • 5Mlinar B, Mlinar B, Marc J, et al. Molecular mechanisms of insulin re sistance and associated diseases [J]. Clin Chim Acta, 2007. 375 (1-2): 20-35.
  • 6Wang CS, Wang ST, Yao WJ, et al. Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study[J]. Am J Epidemiol, 2007, 166(2): 196-203.
  • 7Camma C, Bruno S, Di Marco V, et al. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C[J]. Hepatology, 2006, 43(1): 64-71.
  • 8许波群,李瑛,薛凯,李梅,马翔,刁飞扬,崔毓桂,刘嘉茵.人SET基因小分子干扰RNA重组腺病毒载体的构建与鉴定[J].医学研究生学报,2010,23(2):117-122. 被引量:6
  • 9Mahanivong C, Kro ger JA, Bian D, et al. A simplified cloning strategy for the generation of an endothelial cell selective recombinant adenovirus vector[J]. J Virol Methods, 2006, 135(1): 127-35.
  • 10李小兰,徐向上,李兆明,王桂华,魏欣,罗学来,刘慎沛,肖徽,陶德定,胡俊波,龚建平.HAX1和EGFP共表达重组腺病毒载体的构建、鉴定[J].医学分子生物学杂志,2010,7(1):16-22. 被引量:1

二级参考文献57

  • 1王英杰,王小红,王宇明,李梦东.慢性重型肝炎患者中性粒细胞超微结构的改变[J].新消化病学杂志,1996,4(8):452-453. 被引量:3
  • 2von Lindern M, van Baal S, Wiegant J, et al. Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3 'half to different genes: characterization of the set gene[J]. Mol Cell Biol, 1992, 12(8):3346- 3355.
  • 3Karetsou Z, Martic G, Sflomos G, et al. The histone chaperone SET/TAF-Ibeta interacts functionally with the CREB-binding protein[J]. Biochem Biophys Res Commun, 2005, 335 ( 2 ) : 322- 327.
  • 4Wagner S, Weber S, Kleinschmidt M. A, et al. SET-mediated promoter hypoacetylation is a prerequisite for coactivation of the estrogen-responsive pS2 gene by PRMT1 [J]. J Biol Chem ,2006, 281 ( 37 ) :27242-27250.
  • 5Fan Z, Beresford PJ, Oh DY, et al. Tumor suppressor NM23-HI is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor [ J ]. Cell,2003, 112(5) :659-672.
  • 6Li M, Damuni Z. I1PP2A and I2PP2A. Two potent protein phosphatase 2A-specific inhibitor proteins [ J ]. Methods Mol Biol, 1998, 93:59-66.
  • 7Cervoni N, Detich N, Seo SB, et al. The oncoprotein Set/TAF-1beta, an inhibitor of histone acetyltransferase, inhibits active demethylation of DNA, integrating DNA methylation and transcriptional silencing [ J ]. J Biol Chem, 2002, 277 ( 28 ) : 25026- 25031.
  • 8Ouellet V, Le Page C, Guyot MC, et al. SET complex in serous epithelial ovarian cancer[J]. Int J Cancer, 2006, 119(9 ) :2119- 2126.
  • 9Diao FY, Xu M, Hu Y, et al. The molecular characteristics of polycystie ovary syndrome (PCOS) ovary defined by human ovary eDNA microarray[ J]. J Mol Endocrinol,2004, 33( 1 ) :59-72.
  • 10BENIHOUD K,YEH P, PERRICAUDET M. Adenovirus vectors for gene delivery[ J]. Curr Opin Biotechnol, 1999,10(5) :440-447.

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部